Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1981-1-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0391-3988
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
129-32
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7000714-Epoprostenol,
pubmed-meshheading:7000714-Extracorporeal Circulation,
pubmed-meshheading:7000714-Heparin,
pubmed-meshheading:7000714-Humans,
pubmed-meshheading:7000714-Platelet Aggregation,
pubmed-meshheading:7000714-Prostaglandins,
pubmed-meshheading:7000714-Sulfinpyrazone,
pubmed-meshheading:7000714-Thrombosis
|
pubmed:year |
1980
|
pubmed:articleTitle |
Antiplatelet agents and extracorporeal circulation.
|
pubmed:publicationType |
Journal Article
|